- Home
- AXSM vs CLVT Comparison
AXSM vs CLVT Comparison
Compare AXSM & CLVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | CLVT |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 2.5B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AXSM | CLVT |
|---|---|---|
| Price | $148.15 | $3.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 20 | 3 |
| Target Price | ★ $176.00 | $5.25 |
| AVG Volume (30 Days) | 526.6K | ★ 5.5M |
| Earning Date | 11-03-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $561,263,000.00 | ★ $2,501,200,000.00 |
| Revenue This Year | $66.20 | N/A |
| Revenue Next Year | $57.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 65.83 | N/A |
| 52 Week Low | $75.56 | $3.04 |
| 52 Week High | $152.94 | $5.74 |
Technical Indicators
Market Signals| Indicator | AXSM | CLVT |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 43.37 |
| Support Level | $144.00 | $3.41 |
| Resistance Level | $150.00 | $3.63 |
| Average True Range (ATR) | 4.15 | 0.16 |
| MACD | -0.73 | -0.01 |
| Stochastic Oscillator | 57.42 | 7.45 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.